Safety and Tolerability of HemaMax™ (rHuIL-12) as Radiation Countermeasure

Clinical trial NCT01742221 · COMPLETED

Trial details

NCT number: NCT01742221
Sponsor: Neumedicines Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hematopoietic Syndrome Due to Acute Radiation Syndrome

Start date: 2012-08-01
Primary completion: 2012-11-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.